Diagnosis: Toxic! - Trying to apply approaches of clinical diagnostics and prevalence in toxicology considerations

Toxicological Sciences

Volumn 85, Issue 1, 2005, Pages 422-428

  Hoffmann, Sebastian ^a   Hartung, Thomas ^a  

^a JOINT RESEARCH CENTRE   (Italy)

Author keywords

Biometry; Evidence based medicine; Prevalence; Reference standard; Risk assessment; Validation

Indexed keywords

DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HUMAN; INTOXICATION; LABORATORY DIAGNOSIS; PREVALENCE; QUALITY CONTROL; RELIABILITY; REPRODUCIBILITY; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TOXICITY TESTING; TOXICOLOGY;

DIAGNOSIS; EVIDENCE-BASED MEDICINE; QUALITY CONTROL; REFERENCE STANDARDS; TOXICITY TESTS;

EID: 17444421702     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi099     Document Type: Review

References (32)

1. Allanou, R., Hansen, B. G., and van der Bilt, Y. (1999). Public availability of data on EU High Production Volume Chemicals. EUR 18996 EN (http://ecb.jrc.it).
2. Ames, B. N., and Gold, L. S. (1990). Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad Sci. U.S.A.] 87, 7772-7776.
3. Balls, M., Blaauboer, B. J., Brusick, D., Frazier, J., Lamb, D., Pemberton, M., Reinhardt, C., Roberfroid, M., Rosenkranz, H., Schmid, B., Spielmann, H., Stammati, A. L., and Walum, E. (1990). Report and recommendations of the CAAT/ERGATT workshop on validation of toxicity test procedures. Alt. Lab. Anim. 18, 303-337.
4. Balls, M., Blaauboer, B. J., Fentem, J. H., Bruner, L., Combes, R. D., Ekwall, B., Fielder, R. J., Guillouzo, A., Lewis, R. W., Lovell, D. P., Reinhardt, C. A., Repetto, G., Sladowski, D., Spielmann, H., and Zucco, F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. Alt. Lab. Anim. 23, 129-147.
5. Boyko, E. J., Alderman, B. W., and Baron, A. E. (1988). Reference test errors bias the evaluation of diagnostic tests for ischemic heart disease. J. Gen. Intern. Med. 3, 476-481.
6. Brenner, H., and Gefeller, O. (1997). Variation of sensitivity, specificity, likelihood ratios and predictive values with disease prevalence. Stat. Med. 16, 981-991.
7. Bruner, L. H. (1996). No prediction model, no validation study. Alt. Lab. Anim. 24, 139-142.
8. Bruner, L. H., Carr, G. J., Harbell, J. W., and Curren R. D. (2002). An investigation of new toxicity test method performance in validation studies: 3. Sensitivity and specificity are not independent of prevalence or distribution of toxicity. Hum. Exp. Toxicol. 21, 325-334.
9. Buck, A. A., and Gart, J. J. (1966). Comparison of a screening test and a reference test in epidemiologic studies. I. Indices of agreement and their relation to prevalence. Am. J. Epidemiol. 83, 586-592.
10. Environmental Protection Agency (EPA). (1998). Chemical Hazard Data Availability Study. What do we really know about the safety of high production volume chemicals? EPA's 1998 baseline of hazard information that is readily available to the public. EPA, Office of Pollution Prevention and Toxics, Washington, D.C. (available at: www.epa.gov/opptintr/chemtest/hazchem.htm).
11. Fentem, J. H., Archer, G. E. B., Balls, M., Botham, P. A., Curren, R. D., Earl, L. K., Esdaile, D. J., Holzhütter, H. G., and Liebsch, M. (1998). The ECVAM international study on in vitro tests for skin corrosivity. 2. Results and evaluation by the management team. Toxicol. In Vitro 12, 483-524.
12. Gigerenzer, G., Hoffrage, U., and Ebert, A. (1998). AIDS counselling for low-risk clients. AIDS Care 10, 197-211.
13. Gold, L. S., Slone, T. H., and Ames, B. N. (1998). What do animal cancer tests tell us about human cancer risk?: Overview of analyses of the carcinogenic potency database. Drug Metab. Rev. 30, 359-404.
14. Grimes, D. A., and Schulz, K. F. (2002). Uses and abuses of screening tests. Lancet 359, 881-884.
15. Haynes, R. B., Sackett, D. L., Gray, J. M., Cook, D. J., and Guyatt, G. H. (1996). Transferring evidence from research into practice: 1. The role of clinical care research evidence in clinical decisions. A.C.P. J. Club 125, A14-16.
16. Haynes, R. B., Devereaux, P. J., and Guyatt, G. H. (2002). Clinical expertise in the era of evidence-based medicine and patient choice. Evid. Based Med. 7, 36-38.
17. Hoffmann, S., Cole, T., and Hartung, T. (2005). Skin irritation: Prevalence, variability and regulatory classification of existing in vivo data from industrial chemicals. Regul. Toxicol. Pharmacol. In press.
18. Hunink, M., Glasziou, P., Siegel, J., Weeks, J., Pliskin, J., Eistein, A. S., and Weinstein, M. C. (2001). Decision making in health and medicine: Integrating evidence and values. Cambridge University Press, New York.
19. Irwig, L., Bossuyt, P., Glasziou, P., Gatsonis, C., and Lijmer, J. (2002). Designing studies to ensure that estimates of test accuracy are transferable. B.M.J. 324, 669-671.
20. Knottnerus, J. A., van Weel, C., and Muris, J. W. (2002). Evaluation of diagnostic procedures. B.M.J. 324, 477-480.
21. Knottnerus, J. A., and Muris, J. W. (2003). Assessment of the accuracy of diagnostic tests: the cross-sectional study. J. Clin. Epidemiol. 56, 1118-1128.
22. Linnet, K. (1988). A review on the methodology for assessing diagnostic tests. Clin. Chem. 34, 1379-1386.
23. Marshall, R. J. (1989). The predictive value of simple rules for combining two diagnostic tests. Biometrics 45, 1213-1222.
24. McNeil, B. J., Keller, E., and Adelstein, S. J. (1975). Primer on certain elements of medical decision making. N. Engl. J. Med. 293, 211-215.
25. OECD (Organisation for Economic Cooperation and Development). (2002). OECD guideline for testing of chemicals No. 404: Acute dermal irritation/corrosion, pp. 1-13. Organisation for Economic Cooperation and Development, Paris.
26. Sackett, D. L., Haynes, R. B., Guyatt, G. H., and Tugwell, P. (1991). Clinical epidemiology: A basic science for clinical medicine. 2nd ed., Little Brown, Boston.
27. Sackett, D. L., and Haynes, R. B. (2002). The architecture of diagnostic research. B.M.J. 324, 539-541.
28. van der Schouw, Y. T., Verbeek, A. L., and Ruijs, S. H. (1995). Guidelines for the assessment of new diagnostic tests. Invest. Radiol. 30, 334-340.
29. Walter, S. D., Irwig, L., and Glasziou, P. P. (1999). Meta-analysis of diagnostic tests with imperfect reference standards. J. Clin. Epidemiol. 52, 943-951.
30. Weller, S. C., and Mann, N. C. (1997). Assessing rater performance without a "gold standard" using consensus theory. Med. Decision Making 17, 71-79.
31. Whiting, P., Rutjes, A. W., Reitsma, J., Bossuyt, P. M., and Kleijnen, J. (2003). The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. B.M.C. Med. Res. Methodol. 3, 25.
32. Worth, A., and Balls, M. (2001). The importance of the prediction model in the validation of alternative tests. Alt. Lab. Anim. 29, 135-143.